Cargando…
Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
BACKGROUND: to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT). METHODS: 131 patients affected by intermediate-risk PCa were treated with HyRT at the total dose of 54,75 Gy in 15 fraction plus 9 months of...
Autores principales: | Bracci, Stefano, Osti, Mattia F., Agolli, Linda, Bertaccini, Luca, De Sanctis, Vitaliana, Valeriani, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898326/ https://www.ncbi.nlm.nih.gov/pubmed/27276878 http://dx.doi.org/10.1186/s13014-016-0656-0 |
Ejemplares similares
-
Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy
por: Valeriani, Maurizio, et al.
Publicado: (2013) -
Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results
por: Valeriani, Maurizio, et al.
Publicado: (2014) -
Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
por: Valeriani, Maurizio, et al.
Publicado: (2014) -
Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
por: Valeriani, Maurizio, et al.
Publicado: (2022) -
Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
por: Nicosia, Luca, et al.
Publicado: (2019)